Austin Gillen
Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Single-Cell Analysis | 8 | 2025 | 310 | 1.720 |
Why?
| | Polyadenylation | 4 | 2022 | 42 | 1.590 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 7 | 2019 | 326 | 1.430 |
Why?
| | Programming Languages | 1 | 2025 | 25 | 0.950 |
Why?
| | Hibernation | 2 | 2023 | 75 | 0.900 |
Why?
| | Information Storage and Retrieval | 1 | 2025 | 117 | 0.890 |
Why?
| | Torpor | 2 | 2023 | 14 | 0.850 |
Why?
| | Neoplastic Cells, Circulating | 2 | 2020 | 80 | 0.810 |
Why?
| | Software | 3 | 2025 | 663 | 0.790 |
Why?
| | Transcriptome | 5 | 2024 | 971 | 0.740 |
Why?
| | Leukemia, Myeloid, Acute | 6 | 2024 | 619 | 0.690 |
Why?
| | Sequence Analysis, RNA | 8 | 2025 | 451 | 0.640 |
Why?
| | Gene Expression Regulation | 6 | 2023 | 2603 | 0.620 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 6 | 2025 | 227 | 0.600 |
Why?
| | Ependymoma | 1 | 2020 | 168 | 0.580 |
Why?
| | Chromosomes, Artificial, Bacterial | 2 | 2019 | 19 | 0.580 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2021 | 535 | 0.570 |
Why?
| | Breast Neoplasms | 7 | 2020 | 2239 | 0.540 |
Why?
| | Transgenes | 2 | 2019 | 179 | 0.540 |
Why?
| | Sulfonamides | 6 | 2025 | 512 | 0.530 |
Why?
| | Immunoprecipitation | 2 | 2016 | 155 | 0.520 |
Why?
| | Gene Regulatory Networks | 2 | 2018 | 308 | 0.500 |
Why?
| | Neoplastic Stem Cells | 4 | 2025 | 397 | 0.490 |
Why?
| | Carcinogenesis | 1 | 2017 | 217 | 0.490 |
Why?
| | Artifacts | 1 | 2016 | 129 | 0.480 |
Why?
| | 3' Untranslated Regions | 5 | 2022 | 145 | 0.480 |
Why?
| | Respiratory Mucosa | 1 | 2018 | 322 | 0.470 |
Why?
| | Mitochondrial Proteins | 1 | 2017 | 256 | 0.470 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 424 | 0.450 |
Why?
| | Binding Sites | 2 | 2016 | 1308 | 0.410 |
Why?
| | MicroRNAs | 4 | 2016 | 697 | 0.400 |
Why?
| | Receptors, Estrogen | 5 | 2020 | 436 | 0.390 |
Why?
| | Gene Transfer Techniques | 1 | 2013 | 169 | 0.380 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 2019 | 92 | 0.350 |
Why?
| | Repressor Proteins | 2 | 2011 | 424 | 0.350 |
Why?
| | RNA | 2 | 2023 | 924 | 0.340 |
Why?
| | Cystic Fibrosis | 2 | 2018 | 1104 | 0.330 |
Why?
| | Cell Differentiation | 4 | 2021 | 1980 | 0.310 |
Why?
| | Mammals | 2 | 2023 | 283 | 0.310 |
Why?
| | Homeodomain Proteins | 4 | 2021 | 504 | 0.290 |
Why?
| | Interferon-gamma | 1 | 2011 | 790 | 0.290 |
Why?
| | Gene Expression Regulation, Neoplastic | 6 | 2025 | 1396 | 0.280 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2020 | 278 | 0.260 |
Why?
| | Transcription, Genetic | 2 | 2012 | 1453 | 0.250 |
Why?
| | Animals | 21 | 2025 | 36768 | 0.250 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 3 | 2025 | 1683 | 0.240 |
Why?
| | Humans | 39 | 2025 | 136783 | 0.230 |
Why?
| | Osteolysis | 1 | 2025 | 18 | 0.230 |
Why?
| | Mitochondria | 2 | 2024 | 946 | 0.230 |
Why?
| | Immunoglobulin Light Chains | 1 | 2025 | 47 | 0.230 |
Why?
| | Gene Expression | 2 | 2023 | 1499 | 0.230 |
Why?
| | Mice | 16 | 2025 | 17731 | 0.220 |
Why?
| | Sciuridae | 2 | 2023 | 147 | 0.210 |
Why?
| | Drug Resistance, Neoplasm | 4 | 2025 | 800 | 0.210 |
Why?
| | Signal Transduction | 6 | 2020 | 5065 | 0.210 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2025 | 121 | 0.210 |
Why?
| | MCF-7 Cells | 3 | 2020 | 124 | 0.210 |
Why?
| | Liver | 3 | 2024 | 1938 | 0.210 |
Why?
| | Nonsense Mediated mRNA Decay | 1 | 2023 | 16 | 0.200 |
Why?
| | Lipoproteins, LDL | 2 | 2020 | 117 | 0.200 |
Why?
| | Hematopoietic Stem Cells | 2 | 2024 | 400 | 0.200 |
Why?
| | Protein Isoforms | 2 | 2022 | 400 | 0.200 |
Why?
| | RNA, Messenger | 5 | 2021 | 2831 | 0.200 |
Why?
| | Antineoplastic Agents, Hormonal | 2 | 2021 | 161 | 0.200 |
Why?
| | Muscular Dystrophy, Facioscapulohumeral | 1 | 2023 | 30 | 0.200 |
Why?
| | Lymphatic Vessels | 2 | 2020 | 64 | 0.200 |
Why?
| | Estrogens | 4 | 2018 | 367 | 0.200 |
Why?
| | Liver Cirrhosis | 1 | 2024 | 316 | 0.190 |
Why?
| | Fatty Liver | 1 | 2024 | 242 | 0.190 |
Why?
| | Multiple Myeloma | 1 | 2025 | 253 | 0.180 |
Why?
| | Azacitidine | 2 | 2022 | 141 | 0.180 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 2021 | 68 | 0.180 |
Why?
| | Drosophila | 1 | 2022 | 146 | 0.180 |
Why?
| | Weight Gain | 2 | 2021 | 518 | 0.170 |
Why?
| | Leukocytes, Mononuclear | 2 | 2020 | 556 | 0.170 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2020 | 7 | 0.170 |
Why?
| | Cells, Cultured | 6 | 2019 | 4194 | 0.170 |
Why?
| | Neural Crest | 1 | 2021 | 116 | 0.170 |
Why?
| | rac GTP-Binding Proteins | 1 | 2020 | 32 | 0.160 |
Why?
| | Adipose Tissue | 2 | 2021 | 629 | 0.160 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 30 | 0.160 |
Why?
| | Gene Library | 2 | 2019 | 117 | 0.160 |
Why?
| | Extracellular Fluid | 1 | 2019 | 30 | 0.160 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1500 | 0.160 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 60 | 0.160 |
Why?
| | Integrins | 1 | 2020 | 95 | 0.160 |
Why?
| | Gene Expression Profiling | 7 | 2024 | 1768 | 0.160 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 69 | 0.160 |
Why?
| | Decision Support Systems, Clinical | 1 | 2022 | 218 | 0.150 |
Why?
| | Receptors, Progesterone | 2 | 2020 | 349 | 0.150 |
Why?
| | Hedgehog Proteins | 1 | 2020 | 197 | 0.150 |
Why?
| | Promoter Regions, Genetic | 3 | 2013 | 1250 | 0.150 |
Why?
| | Hematopoiesis | 1 | 2020 | 190 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2025 | 916 | 0.150 |
Why?
| | Neural Stem Cells | 1 | 2020 | 155 | 0.150 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 209 | 0.150 |
Why?
| | RNA Editing | 1 | 2018 | 24 | 0.150 |
Why?
| | Oligodendroglia | 1 | 2020 | 178 | 0.150 |
Why?
| | Calcium | 1 | 2024 | 1197 | 0.150 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2018 | 53 | 0.140 |
Why?
| | Motor Neurons | 1 | 2020 | 234 | 0.140 |
Why?
| | Bleomycin | 1 | 2019 | 247 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 1 | 2019 | 114 | 0.140 |
Why?
| | Zebrafish Proteins | 1 | 2021 | 287 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 913 | 0.140 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2020 | 137 | 0.140 |
Why?
| | RNA Polymerase III | 1 | 2017 | 28 | 0.140 |
Why?
| | Neoplasm Metastasis | 1 | 2020 | 654 | 0.140 |
Why?
| | Superoxide Dismutase | 1 | 2019 | 346 | 0.140 |
Why?
| | Hepatitis C, Chronic | 1 | 2019 | 163 | 0.130 |
Why?
| | Regeneration | 1 | 2019 | 194 | 0.130 |
Why?
| | Progestins | 1 | 2017 | 78 | 0.130 |
Why?
| | Cancer-Associated Fibroblasts | 1 | 2016 | 20 | 0.130 |
Why?
| | Obesity | 2 | 2021 | 2975 | 0.130 |
Why?
| | Zebrafish | 1 | 2021 | 495 | 0.130 |
Why?
| | Macrophages, Alveolar | 1 | 2019 | 392 | 0.130 |
Why?
| | Epididymis | 2 | 2013 | 12 | 0.130 |
Why?
| | Bronchi | 1 | 2018 | 260 | 0.130 |
Why?
| | Transforming Growth Factor beta | 1 | 2019 | 480 | 0.130 |
Why?
| | Trachea | 1 | 2018 | 235 | 0.130 |
Why?
| | Lung Injury | 1 | 2019 | 218 | 0.130 |
Why?
| | Epithelial Cells | 2 | 2013 | 1093 | 0.130 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1274 | 0.120 |
Why?
| | Disease-Free Survival | 1 | 2017 | 687 | 0.120 |
Why?
| | Apoptosis | 3 | 2019 | 2548 | 0.120 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 93 | 0.120 |
Why?
| | Extracellular Matrix | 1 | 2019 | 527 | 0.120 |
Why?
| | Temperature | 1 | 2018 | 674 | 0.120 |
Why?
| | DNA Primers | 1 | 2016 | 513 | 0.120 |
Why?
| | Hypoxia | 1 | 2022 | 1107 | 0.120 |
Why?
| | Sequence Analysis, DNA | 1 | 2018 | 811 | 0.110 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 618 | 0.110 |
Why?
| | CCCTC-Binding Factor | 2 | 2011 | 14 | 0.110 |
Why?
| | Chromosome Mapping | 2 | 2013 | 523 | 0.110 |
Why?
| | Tamoxifen | 3 | 2021 | 202 | 0.110 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 973 | 0.110 |
Why?
| | Neoplasms | 2 | 2021 | 2644 | 0.110 |
Why?
| | Endothelial Cells | 1 | 2019 | 778 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 856 | 0.110 |
Why?
| | Spermatogenesis | 1 | 2013 | 67 | 0.100 |
Why?
| | Infertility, Male | 1 | 2013 | 61 | 0.100 |
Why?
| | Mice, Inbred C57BL | 5 | 2024 | 5744 | 0.100 |
Why?
| | Nucleosomes | 2 | 2013 | 155 | 0.100 |
Why?
| | Down-Regulation | 1 | 2015 | 657 | 0.100 |
Why?
| | Cluster Analysis | 3 | 2022 | 495 | 0.100 |
Why?
| | Enhancer Elements, Genetic | 2 | 2012 | 190 | 0.100 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 103 | 0.100 |
Why?
| | Cell Line, Tumor | 4 | 2025 | 3399 | 0.100 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2014 | 219 | 0.100 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2013 | 317 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2013 | 321 | 0.090 |
Why?
| | Genes, Regulator | 1 | 2011 | 37 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2015 | 530 | 0.090 |
Why?
| | Caco-2 Cells | 1 | 2011 | 76 | 0.090 |
Why?
| | Luciferases | 1 | 2011 | 150 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1942 | 0.090 |
Why?
| | Oxidative Phosphorylation | 2 | 2024 | 193 | 0.090 |
Why?
| | Mice, Transgenic | 3 | 2021 | 2162 | 0.090 |
Why?
| | RNA Processing, Post-Transcriptional | 1 | 2011 | 92 | 0.090 |
Why?
| | Hypertension, Pulmonary | 1 | 2022 | 1902 | 0.090 |
Why?
| | Female | 12 | 2024 | 72840 | 0.080 |
Why?
| | Tumor Microenvironment | 3 | 2020 | 671 | 0.080 |
Why?
| | Protein Binding | 1 | 2016 | 2223 | 0.080 |
Why?
| | Insulator Elements | 1 | 2009 | 2 | 0.080 |
Why?
| | 3' Flanking Region | 1 | 2009 | 7 | 0.080 |
Why?
| | Blotting, Western | 1 | 2011 | 1225 | 0.070 |
Why?
| | CD146 Antigen | 2 | 2020 | 41 | 0.070 |
Why?
| | Inflammation | 1 | 2019 | 2834 | 0.070 |
Why?
| | Prognosis | 3 | 2025 | 4018 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2020 | 953 | 0.070 |
Why?
| | Disease Models, Animal | 3 | 2024 | 4279 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2669 | 0.060 |
Why?
| | Male | 10 | 2025 | 67361 | 0.060 |
Why?
| | Blast Crisis | 1 | 2025 | 33 | 0.060 |
Why?
| | Chromatin | 1 | 2009 | 518 | 0.060 |
Why?
| | Antigens, CD34 | 1 | 2023 | 88 | 0.050 |
Why?
| | Disease Progression | 2 | 2023 | 2750 | 0.050 |
Why?
| | Serine-Arginine Splicing Factors | 1 | 2023 | 22 | 0.050 |
Why?
| | Bone Marrow Cells | 1 | 2024 | 316 | 0.050 |
Why?
| | Bone Marrow | 1 | 2024 | 286 | 0.050 |
Why?
| | Mice, Obese | 1 | 2021 | 66 | 0.050 |
Why?
| | Aromatase Inhibitors | 1 | 2021 | 53 | 0.050 |
Why?
| | Thinness | 1 | 2021 | 91 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 40 | 0.040 |
Why?
| | Organogenesis | 1 | 2021 | 58 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 29 | 0.040 |
Why?
| | Child | 1 | 2020 | 21968 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 162 | 0.040 |
Why?
| | Embryoid Bodies | 1 | 2020 | 8 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 166 | 0.040 |
Why?
| | Colony-Forming Units Assay | 1 | 2020 | 91 | 0.040 |
Why?
| | Head | 1 | 2021 | 105 | 0.040 |
Why?
| | Skull | 1 | 2021 | 139 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2024 | 721 | 0.040 |
Why?
| | Cartilage | 1 | 2021 | 188 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2020 | 247 | 0.040 |
Why?
| | Tricarboxylic Acids | 1 | 2018 | 10 | 0.040 |
Why?
| | Exocytosis | 1 | 2019 | 89 | 0.040 |
Why?
| | Ketoglutaric Acids | 1 | 2018 | 16 | 0.040 |
Why?
| | Mesoderm | 1 | 2020 | 144 | 0.040 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2019 | 130 | 0.040 |
Why?
| | Electron Transport Complex II | 1 | 2018 | 26 | 0.040 |
Why?
| | Transcription Factors | 2 | 2021 | 1714 | 0.040 |
Why?
| | Succinate Dehydrogenase | 1 | 2018 | 49 | 0.040 |
Why?
| | DNA, Complementary | 1 | 2019 | 269 | 0.040 |
Why?
| | Gene Editing | 1 | 2019 | 82 | 0.040 |
Why?
| | Primary Cell Culture | 1 | 2019 | 171 | 0.040 |
Why?
| | Loss of Function Mutation | 1 | 2018 | 46 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2020 | 467 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2020 | 507 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 327 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 342 | 0.040 |
Why?
| | Lung | 2 | 2022 | 4065 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 233 | 0.030 |
Why?
| | Fatty Acids | 1 | 2020 | 444 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 487 | 0.030 |
Why?
| | Amino Acids | 1 | 2020 | 500 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2019 | 7569 | 0.030 |
Why?
| | Fibrosis | 1 | 2019 | 551 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2020 | 613 | 0.030 |
Why?
| | Mice, SCID | 1 | 2017 | 367 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 590 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2017 | 350 | 0.030 |
Why?
| | Mice, Inbred NOD | 1 | 2017 | 601 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 65 | 0.030 |
Why?
| | Aged | 3 | 2020 | 23729 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 885 | 0.030 |
Why?
| | Fibroblasts | 1 | 2020 | 989 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2017 | 864 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1541 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2018 | 488 | 0.030 |
Why?
| | Receptors, Steroid | 1 | 2014 | 50 | 0.030 |
Why?
| | Expert Systems | 1 | 2013 | 3 | 0.030 |
Why?
| | DNA, Intergenic | 1 | 2013 | 26 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2014 | 306 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2129 | 0.030 |
Why?
| | Organ Specificity | 1 | 2013 | 304 | 0.030 |
Why?
| | Chronic Disease | 1 | 2019 | 1784 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2018 | 918 | 0.020 |
Why?
| | RNA Interference | 1 | 2014 | 464 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2019 | 2999 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2190 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2013 | 765 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2011 | 240 | 0.020 |
Why?
| | Diet | 1 | 2018 | 1273 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5628 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2017 | 2473 | 0.020 |
Why?
| | DNA Footprinting | 1 | 2009 | 33 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2009 | 39 | 0.020 |
Why?
| | Fetus | 1 | 2013 | 806 | 0.020 |
Why?
| | Computational Biology | 1 | 2013 | 645 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4158 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2180 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2022 | 10764 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2013 | 1434 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2831 | 0.020 |
Why?
| | Adult | 2 | 2019 | 37616 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 33200 | 0.010 |
Why?
|
|
Gillen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|